World News

ESMO launches new principles for humanising scientific reporting to strengthen the...

Ogkologos - 21 Οκτωβρίου, 2026

Clinical Activity of Talazoparib Plus Enzalutamide Demonstrated in Patients with High-Volume...

Ogkologos - 20 Οκτωβρίου, 2026

FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma

Ogkologos - 19 Οκτωβρίου, 2026

Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and...

Ogkologos - 16 Οκτωβρίου, 2026

Meet the first recipient of the ESMO Artificial Intelligence Fellowship

Ogkologos - 16 Οκτωβρίου, 2026

EMA Recommends Granting a Marketing Authorisation for Senaparib

Ogkologos - 15 Οκτωβρίου, 2026

UN Pandemic Declaration Reflects Key ESMO Priorities

Ogkologos - 14 Οκτωβρίου, 2026

Cancer vaccines and the next frontier in melanoma: From headlines to...

Ogkologos - 14 Οκτωβρίου, 2026

Five-Year Survival Outcomes with Neoadjuvant Therapy in Melanoma Demonstrate that Neoadjuvant...

Ogkologos - 13 Οκτωβρίου, 2026

Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated...

Ogkologos - 12 Οκτωβρίου, 2026

1 234...432 Σελίδα 3 από 432

MOST POPULAR

Por qué no voy a “superar” los efectos a largo plazo...

20 Ιουλίου, 2021

News digest – targeted ‘lava lamp’ treatment, skin cancer biopsies and...

20 Ιουνίου, 2020

Helping Cancer Survivors Cope with Cancer-Related Anxiety and Distress

30 Απριλίου, 2020

EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab

28 Απριλίου, 2021

Φόρτωση περισσοτέρων

ESMO launches new principles for humanising scientific reporting to strengthen the...

Clinical Activity of Talazoparib Plus Enzalutamide Demonstrated in Patients with High-Volume...

FDA Approves Daraxonrasib for Metastatic Pancreatic Adenocarcinoma

Chemotherapy-Free Regimen of Targeted Agent and Immunotherapeutic Superior to Imatinib and...

Meet the first recipient of the ESMO Artificial Intelligence Fellowship

EMA Recommends Granting a Marketing Authorisation for Senaparib

UN Pandemic Declaration Reflects Key ESMO Priorities

Cancer vaccines and the next frontier in melanoma: From headlines to...

Five-Year Survival Outcomes with Neoadjuvant Therapy in Melanoma Demonstrate that Neoadjuvant...

Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated...

MOST POPULAR

Por qué no voy a “superar” los efectos a largo plazo...

News digest – targeted ‘lava lamp’ treatment, skin cancer biopsies and...

Helping Cancer Survivors Cope with Cancer-Related Anxiety and Distress

EMA Recommends Extension of Therapeutic Indications for Nivolumab and Ipilimumab

HOT NEWS

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Cancer research could revive the UK’s ailing public finances

FDA Approves Pralsetinib for Non-Small Cell Lung Cancer with RET Gene...

What to Know About 3 Common Misconceptions Around Food and Cancer...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ